Sanofi · 10 hours ago
Remote Veeva Content QA & Submission Lead – Healthcare Marketing (contract)
United States
Contract
Remote
Mid Level
3+ years expSanofi is seeking a Content Quality & Submission Lead for their FLEXT Direct contingent workforce program. This role involves managing the quality, compliance, and submission of digital promotional materials within the Veeva platform, ensuring that all content is submission-ready and meets regulatory standards.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Manage submission of promotional assets into Veeva
Perform end-to-end quality control of digital promotional materials
Ensure accurate anchoring, version control, and submission readiness
Translate RC and MLR feedback into actionable updates for content teams
Review claims, references, ISI, formatting, and overall compliance
Support development and maintenance of core claims libraries
Coordinate workflows and track projects to ensure timelines and quality standards are met
Act as a liaison between marketing, regulatory, medical, legal, writers, and designers
Qualification
Required
Minimum 3 years of relevant experience in content quality, submission, or compliance roles
Required experience with Veeva (Vault PromoMats or similar)
Experience working in a regulated environment
Strong attention to detail and organizational skills
Ability to manage multiple projects and stakeholders simultaneously
Excellent written and verbal communication skills
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
BioWorld Financial Watch
2026-02-04
Company data provided by crunchbase